Prime Therapeutics co-prefers Praluent, Repatha to reduce cholesterol
Pharmacy benefit manager Prime Therapeutics recently added two FDA-approved cholesterol lowering drugs to its preferred national drug list. Read More »
Pharmacy benefit manager Prime Therapeutics recently added two FDA-approved cholesterol lowering drugs to its preferred national drug list. Read More »
The Electronic Healthcare Network Accreditation Commission (EHNAC) this week released the final 2016 criteria versions for 18 accreditation programs. Read More »
Canadian pharmaceutical company Acerus announced last week that its contract with Endo Ventures Bermuda Limited to commercialize NATESTO, a testosterone replacement nasal gel, will be terminated effective June 30. Read More »
Mylan brought its generic form of Pfizer's bacteria-fighting drug Zyvox to market on Tuesday. Read More »
ProHealth Physicians (ProHealth), one of the largest independent physician groups in Connecticut, recently joined the OptumCare organization to improve the quality of care for its 360,000-plus active patients. Read More »
The Lynx Group, a global alliance of medical communication and education companies, and the National Association of Specialty Pharmacy (NASP), a trade association representing the specialty pharmacy industry, recently partnered for an upcoming expo. Read More »
Health insurer WellCare Health Plans Inc. transferred its pharmacy benefit management (PBM) to CVS Health, the second largest PBM company in the nation, Friday. Read More »
Managed health care company Aetna recently launched new individual health plans through accountable care agreements with PinnacleHealth System and Leigh Valley Health Network's preferred provider organization Valley Preferred. Read More »
Pharmaceutical return services provider Guaranteed Returns recently introduced a new program that delivers quick payments to pharmacies. Read More »
Julian Baker was recently appointed to the board of directors at Acadia Pharmaceuticals. Read More »
The Academy of Managed Care Pharmacy (AMCP) Foundation released a report Dec. 23, summarizing the highlights of its Fifth Annual Symposium that addressed chronic disease in the United States. Read More »
Donna West-Strum, a University of Mississippi department chair and professor in the School of Pharmacy, was recently recognized for her role in creating the University’s Educating Pharmacists in Quality (EPIQ) program. Read More »
Praxsyn Corporation, a diversified share-holding company that finds non-traditional solutions to fit the needs and goals of its clientele, appointed James Bradford, executive partner and founder of Products for Doctors Inc., to its board of directors Dec. 21. Read More »
Global generic and specialty pharmaceutical company Mylan N.V.'s offer to acquire all issued and to-be-issued share capital of Perrigo Company plc expired Nov. 22. Read More »
PharMerica Corporation, a leading provider of institutional and specialty pharmacy services, recently acquired two pharmacies that generated at least $100 million of annualized sales, in aggregate, this year. Read More »
The Food and Drug Administration (FDA) approved AstraZeneca's drug Zurampic Dec. 22 as a combination treatment for gout. Read More »
PixarBio Corporation expanded its regulatory team Monday with the addition of Steven Chartier as the vice president of the biotechnology company's regulatory affairs. Read More »
German drugmaker Merck KGaA and American-based drug giant Pfizer recently initiated two new clinical trials involving the PD-L1 inhibitor known as avelumab. Read More »
The National Association of Chain Drug Stores (NACDS) is working with the U.S. House of Representatives to support pharmacists' role in a new pilot program to advance medication therapy management (MTM) for Medicare patients. Read More »
Zoll Manufacturing Corporation's LifeVest wearable defibrillator was approved by the Food and Drug Administration (FDA) Dec. 17 for children at risk of sudden cardiac arrest. Read More »